Characteristics of Thymus Hormones
Thymus hormones play a crucial role in endocrine regulation and immune response. Their effects are diverse and affect both cellular and humoral immunity.
Thymosins In vitro, these substances act as potent stimulators of immune processes. They promote T-lymphocyte differentiation and the expression of specific receptors on their surface. Additionally, thymosins activate lymphokine production and stimulate immunoglobulin synthesis.
Thymopoietins This group of hormones is localized in the nuclei of the epithelial framework of the thymus, as well as in basal keratinocytes of the epidermis. Key functions of thymopoietins:
- Initiating the maturation of prothymocytes into mature T cells (without altering the immunological profile of the cells).
- Direct interaction with cholinergic receptors.
- Altering the secretory activity of corticotrophs located in the pituitary gland.
In clinical practice, thymopentin is widely used—a drug representing a fragment of thymopoietin (comprising amino acid residues 32–36). It is indispensable in treating primary immunodeficiency states, specifically DiGeorge syndrome.
Parathymosin This is a polypeptide analog of prothymosin. Its physiological action largely duplicates the effects characteristic of thymosin.
Etiotropic Principle of Therapy
Etiotropic treatment is always directed at the root cause of the disease. The primary task of the physician in this case is to completely eliminate, stop, or at least reduce the intensity and duration of pathogenic factors acting on endocrine gland tissues.
Factors that require mandatory and primary elimination include physical insults. Among the most significant threats are high-dose radiation and direct mechanical trauma to the glandular tissue. Without halting these triggers, further restoration of organ function is impossible.
Pathogenetic Therapy
If etiotropic therapy targets the cause, pathogenetic therapy targets the mechanisms of disease development. Its main goal is to block pathological processes at the molecular, cellular, and tissue levels.
Therapy should support the optimal progression of the following processes:
- Direct hormone synthesis within glandular cells.
- Transport of hormone molecules in the bloodstream and interstitial fluid.
- Binding and interaction of hormones with specific cellular receptors.
- Adequate intracellular metabolism.
To implement this principle, two main methods are used:
- Administration of hormone preparations. This path is used in replacement therapy when the body experiences a deficit of its own hormones or an insufficiency of their physiological effects.
- Administration of hormone blockers and antagonists. This tactic is justified in cases of pathological glandular hyperactivity or excessive hormone production, when it is necessary to artificially reduce their influence on target organs.
Symptomatic Therapy
Even with the successful elimination of the cause and the blocking of disease mechanisms, a patient may suffer from severe clinical manifestations. The goal of symptomatic therapy is to prevent or eliminate distressing symptoms that significantly worsen the patient's general condition.
As part of symptomatic correction, the following groups of medications are used:
- Anti-stress agents helping the nervous system cope with load.
- Blood pressure medications (antihypertensives for hypertension or vasopressors for hypotension).
- Tranquilizers to reduce anxiety and emotional stress.
- Various substances that promote the normalization of metabolic processes and restore lost functions of organs and entire physiological systems.